- Location
Valeant
"-
Pershing Square Sells 20 Million Shares In Mondelez
Mar 18, 2016Pershing Square, a hedge fund run by investor Bill Ackman, has sold 20 million shares of US-based confectionery giant Mondelez International. Following the sale, the investor now owns only a 5.6% of the confectionery company. In a ...
Tags: Pershing Square, Bill Ackman, Mondelez
-
Allergan Fought off Hostile Takeover Attempt by Valeant Pharmaceuticals for Past 8 Months
Dec 17, 2014Posted in Medical Device Business by Nancy Crotti on December 15, 2014 Just when you thought they couldn’t get more widespread or expensive, the medical device mergers-and-acquisitions of 2014 continue to astound. Allergan ...
Tags: DNA sequencing market, lab products, Health
-
Five Companies with The Most Stock Price Growth Over 2014
Dec 15, 2014Posted in Medical Device Business by Chris Newmarker on December 11, 2014 2014 has turned out to be a pretty decent year for the world’s 40 largest medical device companies: Only six of them have seen their stock prices decline, and ...
Tags: Medical Device, Health
-
The Deal Helped Propel The Dow and S&P 500 to Record Highs on November 8
Nov 19, 2014Posted in Medical Device Business by Brian Buntz on November 18, 2014 Irvine, CA–based Allergan has been adamant in fighting off a hostile takeover attempt from Valeant Pharmaceuticals International for the past seven months. But ...
Tags: silicone breast, Botox, Health
-
The Medtech Jobs Picture Looked Rosy in 2013
Aug 14, 2014The medtech jobs picture looked rosy in 2013, with the top 15 device makers in hiring mode, according to an EP Vantage report out this week. Excluding pharmaceutical spinoffs, these companies expanded their collective workforce by 6%, the ...
Tags: Medtech Jobs, Health, Medicine
-
Mylan Today Announced That Subsidiary Mylan Pharmaceuticals and Partner,Banner Pharmacaps
Dec 19, 2013Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. and partner, Banner Pharmacaps Inc. (a wholly-owned subsidiary of Patheon Inc.), have entered into a settlement and license agreement with Eisai Inc. ...
Tags: Mylan, Targretin Suit, Treatment of Cutaneous Manifestations
-
Rainbow Coral and Its Joint Venture Partner Have Reached a Major New Milestone
Dec 16, 2013Rainbow Coral and its joint venture partner, Therakine, have reached a major new milestone in the development of a revolutionary new drug delivery technology. The companies reached terms to initiate Phase II of research and analysis on a ...
Tags: RBCC, Drug Delivery Development
-
Valeant Pharmaceuticals Has Been Approved by The Us FDA
Nov 20, 2013Valeant Pharmaceuticals North America, a wholly-owned subsidiary of Valeant Pharmaceuticals International, has received a notice that the new drug application for Luzu (luliconazole) cream, 1% has been approved by the US Food and Drug ...
-
FDA Clearance for New Monthly Disposable Contact Lens Is Obtained by Bausch + Lomb
Oct 8, 2013Bausch + Lomb, a subsidiary of Valeant Pharmaceuticals International, has obtained marketing clearance from the US Food and Drug Administration (FDA) for its newest frequent replacement silicone hydrogel contact lenses made with ...
Tags: Contact Lens, Medicine
-
Canadian Regulatory Authority Health Canada Has Approved New Drug Submission
Oct 8, 2013Canadian regulatory authority Health Canada has approved Valeant Pharmaceuticals International subsidiary Valeant Canada's new drug submission of Jublia for the treatment of onychomycosis. Jublia is designated for the treatment of mild to ...
Tags: Fungal Drug, Medicine
-
Valeant Pharmaceuticals Closed The Acquisition of Bausch + Lomb Holdings for $8.7bn
Aug 12, 2013Valeant Pharmaceuticals International has closed the acquisition of Bausch + Lomb Holdings, a US-based manufacturer of eye health products, for $8.7bn. Bausch + Lomb Holdings has a broad portfolio of eye health products, including OTC ...
Tags: Valeant Pharmaceuticals
-
US Stocks Pushed to Highest Levels as Investors Await Fed Move on Stimulus
Jun 19, 2013US stocks pushed to the highest levels in nearly three weeks as investors await news on whether the Federal Reserve will pull back on its stimulus measures. Small-company stocks were among the best performers in Tuesday's rally, with the ...
-
Sun Is Said to Be in Advanced Negotiations to Acquire Sweden-Based Meda in a Deal
Jun 4, 2013India-based drugmaker Sun Pharmaceutical Industries is said to be in advanced negotiations to acquire Sweden-based Meda in a deal valued at $5-$6bn. Sources close to the deal were quoted by Reuters as saying that the acquisition will ...
-
Valeant Agrees to Acquire Contact Lenses Developer Bausch + Lomb Holdings for $8.7bn
May 29, 2013Dermatology products developer Valeant Pharmaceuticals International has entered into a definitive agreement to acquire contact lenses developer Bausch + Lomb Holdings for a cash consideration of $8.7bn, as part of its strategy to enhance ...
-
FDA Has Warned The People That The Anti-Seizure Drug, Potiga
May 13, 2013The US Food and Drug Administration (FDA) has warned the people that the anti-seizure drug, Potiga, developed by Valeant Pharmaceuticals and co-marketed with GlaxoSmithKline, may cause eye and skin problems. FDA warned that Potiga may ...
Tags: Anti-Seizure Drug Potiga, Medicine
